General MedicationsORAL-28Standard

LEVONORGESTREL AND ETHINYL ESTRADIOL

ETHINYL ESTRADIOL; LEVONORGESTREL

Standard Dose

0.03MG;0.15MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview LEVONORGESTREL AND ETHINYL ESTRADIOL is listed in Drugs@FDA under application 207033 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ETHINYL ESTRADIOL; LEVONORGESTREL Form and strength TABLET;ORAL-28 - 0.03MG;0.15MG Sponsor NAARI PTE Submission history Latest submission status date: 2022-04-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVONORGESTREL AND ETHINYL ESTRADIOL is listed in Drugs@FDA under application 207033 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ETHINYL ESTRADIOL; LEVONORGESTREL Form and strength TABLET;ORAL-28 - 0.03MG;0.15MG Sponsor NAARI PTE Submission history Latest submission status date: 2022-04-29 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.